Expression of p21WAF1 and p53 and polymorphism of p21WAF1 gene in gastric carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 8, 2004, Pages 1125-1131

  Xie, Hai Long ^a   Su, Qi ^a   He, Xiu Sheng ^a   Liang, Xiao Qiu ^a   Zhou, Jian Guo ^a   Song, Yin ^a   Li, Yi Qin ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE; PROTEIN P21; PROTEIN P53; STREPTAVIDIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; DYSPLASIA; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE METASTASIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNET RING CARCINOMA; STATISTICAL SIGNIFICANCE; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

EID: 2342419614     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i8.1125     Document Type: Article

References (64)

1. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF, A potential mediator of P53 tumor suppression. Cell 1993; 75: 817-824
2. Waga S, Hannon GJ, Beach D, Stillman B. The P21WAF1 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574-578
3. Sherr CJ. Carcinoma cell cycles. Science 1996; 274: 1672-1677
4. Seo YH, Joo YE, Choi SK, Rew JS, Park CS, Kim SJ. Prognostic significance of p21 and p53 expression in gastric cancer. Korean J Intern Med 2003; 18: 98-103
5. Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Hepatogastroenterology 1999; 46: 2648-2653
6. Park YE, Choi KC, Choi YH. p21 expression and mutation in gastric carcinoma: analysis by immunohistochemistry and PCR-SSCP. J Korean Med Sci 1998; 13: 507-512
7. Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K. Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinom. Oncology 2002; 63: 353-361
8. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K. Growth pattern and expressions of cell cycle regulator proteins p53 and p21WAF1/CIP1 in early gastric carcinoma. Cancer 2001; 92: 1828-1835
9. Tahara E. Molecular biology of gastric cancer. World J Surg 1995; 19: 484-490
10. Ueno H, Hirai T, Nishimoto N, Hihara J, Inoue H, Yoshida K, Yamashita Y, Toge T, Tsubota N. Prediction of lymph node metastasis by p53, p21 (Waf1), and PCNA expression in esophageal cancer patients. J Exp Clin Cancer Res 2003; 22: 239-245
11. Xie X, Clausen OP, Boysen M. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 2002; 128: 897-902
12. Yen-Ping Kuo M, Huang JS, Kok SH, Kuo YS, Chiang CP. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 2002; 31: 16-22
13. Amatya VJ, Takeshima Y, Sugiyama K, Kurisu K, Nishisaka T, Fukuhara T, Inai K. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 2001; 32: 970-975
14. Holm R, Skovlund E, Skomedal H, Florenes VA, Tanum G. Reduced expression of p21WAF1 is an indicator of malignant behaviour in anal carcinomas. Histopathology 2001; 39: 43-49
15. Seta T, Imazeki F, Yokosuka O, Saisho H, Suzuki T, Koide Y, Isono K. Expression of P53 and P21 WAF1 proteins in gastric and esophageal carcinomas comparison with mutations of P53 gene. Dig Dis Sci 1998; 43: 279-289
16. Parkin DM. Global carcinoma statistics in the year 2000. Lancet Oncol 2001; 2: 533-543
17. Zheng ZH, Xun XJ, Qiu GR, Liu YH, Wang MX, Sun KL. E-cadherin gene mutation in precarcinomaous condition, early and advanced stage of gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2002; 10: 153-156
18. Cheng SD, Wu YL, Zhang YP, Qiao MM, Guo QS. Abnormal drug accumulation in multidrug resistant gastric carcinoma cells. Shijie Huaren Xiaohua Zazhi 2001; 9: 131-134
19. Chen GY, Wang DR. The expression and clinical significance of CD44v in human gastric cancers. World J Gastroenterol 2000; 6: 125-127
20. Wang RQ, Fang DC, Liu WW. MUC2 gene expression in gastric cancer and preneoplastic lesion tissues. Shijie Huaren Xiaohua Zazhi 2000; 8: 285-288
21. Guo YQ, Zhu ZH, Li JF. Flow cytometric analysis of apoptosis and proliferation in gastric cancer and precancerous lesion. Shijie Huaren Xiaohua Zazhi 2000; 8: 983-987
22. Chen SY, Wang JY, Ji Y, Zhang XD, Zhu CW. Effects of Helicobacter pylori and protein kinase C on gene mutation in gastric carcinoma and precarcinomaous lesions. Shijie Huaren Xiaohua Zazhi 2001; 9: 302-307
23. Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol 2001; 7: 403-406
24. Wu K, Zhao Y, Liu BH, Li Y, Liu F, Guo J, Yu WP. RRR-α-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest. World J Gastroenterol 2002; 8: 26-30
25. He XS, Su Q, Chen ZC, He XT, Long ZF, Ling H, Zhang LR. Expression,deletion and mutation of p16 gene in gastric cancer. World J Gastroenterol 2001; 7: 515-521
26. Sun XD, Mu R, Zhou YS, Dai XD, Qiao YL, Zhang SV, Huangfu XM, Sun J, Li LD, Lu FZ. 1990-1992 mortality of stomach carcinoma in China. Zhongguo Zhongliu Zazhi 2002; 24: 4-8
27. Yang L, Kuang LG, Zheng HC, Li JY, Wu DY, Zhang SM, Xin Y. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 2003; 9: 35-39
28. Facher EA, Becich MJ, Deka A, Law JC. Association between human carcinoma and two polymorphism, occurring together in the P21Waf1/Cip1 cyclin-dependent kinase inhibitor gene. Cancer 1997; 79: 2424-2429
29. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82: 675-684
30. Cho JH, Kim WH. Altered topographic expression of 21WAF1/CIP1/ SDI1, bcl2 and p53 during gastric carcinogenesis. Pathol Res Pract 1998; 194: 309-317
31. Zolota V, Batistatou A, Tsamandas AC, Iliopoulos G, Scopa CD, Bonikos DS. Immuno- histochemical expression of TGF-beta1, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study. Int J Gastrointest Cancer 2002; 32: 83-89
32. Liu XP, Kawauchi S, Oga A, Suehiro Y, Tsushimi K, Tsushimi M, Sasaki K. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Histopathology 2001; 39: 603-610
33. Baldus SE, Schneider PM, Monig SP, Zirbes TK, Fromm S, Meyer W, Glossmann J, Schuler S, Thiele J, Holscher AH, Dienes HP. p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol 2001; 36: 975-980
34. Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T, Sasaki K. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis. Cancer Lett 2001; 170: 183-189
35. Ogawa M, Onoda N, Maeda K, Kato Y, Nakata B, Kang SM, Sowa M, Hirakawa K. A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis. Int J Mol Med 2001; 7: 479-483
36. Oya M, Yao T, Tsuneyoshi M. Expressions of cell-cycle regulatory gene products in conventional gastric adenomas: possible immunohisto- chemical markers of malignant transformation. Hum Pathol 2000; 31: 279-287
37. Kaye PV, Radebold K, Isaacs S, Dent DM. Expression of p53 and p21waf1/cip1 in gastric carcinoma: lack of inter-relationship or correlation with prognosis. Eur J Surg Oncol 2000; 26: 39-43
38. Huang J, Gan J. Relationship between expression of tumor suppressor protein p21 and p53 and cell proliferation in the gastric carcinoma. Hunan Yike Daxue Xuebao 1998; 23: 441-443
39. Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999; 189: 481-486
40. Tatebe S, Matsuura T, Endo K, Teramachi K, Nakamura T, Sato K, Ito H. A denovirus- mediated transfer of wild-type p53 gene results in apoptosis or growth arrest in human cultured gastric carcinoma cells. Int J Oncol 1999; 15: 229-235
41. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N. Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma. Dig Dis Sci 1998; 43: 964-970
42. Ikeguchi M, Saito H, Katano K, Gomyo Y, Tsujitani S, Maeta M, Kaibara N. Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and p21 in patients with gastric carcinoma at stage IIIa and stage IIIb. Int Surg 1997; 82: 170-174
43. Gomyo Y, Ikeda M, Osaki M, Tatebe S, Tsujitani S, Ikeguchi M, Kaibara N, Ito H. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 1997; 79: 2067-2072
44. Ogawa M, Maeda K, Onoda N, Chung YS, Sowa M. Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer 1997; 75: 1617-1620
45. Akarna Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T, Tahara E. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87: 824-830
46. Akagi M, Yasui W, Akama Y, Yokozaki H, Tahara H, Haruma K, Kajiyama G, Tahara E. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53- independent induction of p21 in gastric carcinoma cells. Jpn J Cancer Res 1996; 87: 377-384
47. Qian LP, Lin GJ. Relationship of WAF1 and p53 in human gastric carcinomas. Shanghai Yike Daxue Xuebao 1998; 25: 416-418
48. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997; 57: 3381-3385
49. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997; 3: 231-233
50. Kip1 protein: prognostic implications in primary breast carcinoma. Nat Med 1997; 3: 227-230
51. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM. Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast carcinoma patients. Nat Med 1997; 3: 222-225
52. Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998; 58: 542-548
53. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K. Growth pattern and expressions of cell cycle regulator proteins p53 and p21WAF1/CIP1 in early gastric carcinoma. Cancer 2001; 92: 1828-1835
54. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS. Arrest of the cell cycle by the tumor-suppressor BRCA1 requires the CDK-inhibitor P21WAF1. Nature 1997; 389: 187-190
55. Jiang M, Shao Z, Wu J. WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features. Zhonghua Zhongliu Zazhi 1998; 20: 181-184
56. Yook JL, kin J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 1998; 34: 198-203
57. Liu Y, Martindale JL, Gorospe M, Holbrook NJ. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 1996: 56: 31
58. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994; 84: 3781-3784
59. Akama Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T, Tahara E. No point mutations but codon 31 polymorphism and decreased expressed of the P21WAF1 gene in human gastric carcinomas. Mol Cell Differen 1996; 4: 187-198
60. Powell BL, van Staveren IL, Roosken P, Grieu F, Berns EM, Iacopetta B. Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer. Carcinogenesis 2002; 23: 311-315
61. Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum Mol Genet 1995; 4: 1089-1092
62. Schmidt-Grimminger DC, Wu X, Jian Y, Broker TR, Chow LT. Post-transcriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities. Am J Pathol 1998; 152: 1015-1024
63. Shin JY, Kim HS, Park J, Park JB, Lee JY. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res 2000; 60: 262-265
64. Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T. p21 expression is a prognostic factor in patients with p53-negative gastric cancer. Cancer Lett 2000; 148: 181-188